Brief: Biocartis Partners With Lilly On Biomarker Testing For NSCLC Patients Using Idylla Platform
10/08/2023 06:10
Aug 10 (Reuters) - Biocartis Group NV BCART.BR :
* BIOCARTIS PARTNERS WITH LILLY TO EXPLORE BIOMARKER TESTING
FOR
NSCLC PATIENTS USING THE IDYLLA PLATFORM
Source text for Eikon: ID:nGNE6VtTT9
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies